From the Journals

Chronic Liver Disease in Latinx Pediatric Patients: Risk Factor Potentially Identified as Cases Rise

Investigators may have uncovered a new factor contributing to the rising incidence of metabolic dysfunction–associated steatotic liver disease among Latinx pediatric patients.

Share

  • 1

    The study uncovers the link between food insecurity at 4 years of age and the development of metabolic dysfunction–associated steatotic liver disease in Latinx pediatric patients.

  • 2

    Exposure to food insecurity at 4 years of age was correlated with a 3.7-fold increased likelihood of developing the disease in childhood.

  • 3

    Among the pediatric patients involved in the study, 28.7% experienced food insecurity at 4 years of age and 27.2% developed metabolic dysfunction–associated steatotic liver disease by middle childhood.

  • 4

    A greater proportion of patients with the disease experienced food insecurity compared with those without the disease (49.0% vs 21.0%).

  • 5

    Screening for metabolic dysfunction–associated steatotic liver disease and food insecurity is important early on, especially for Latinx children who are at higher risk.

Original Source(s)

Chronic Liver Disease in Latinx Pediatric Patients: Risk Factor Potentially Identified as Cases Rise

Investigators may have uncovered a new factor contributing to the rising incidence of metabolic dysfunction–associated steatotic liver disease among Latinx pediatric patients.

  • by Conexiant News Staff

  • May 1, 2024

  • 2 min

Related Content

Liver Supplements: Big Sales, Limited Evidence

Researchers evaluate how popular liver cleanse products are formulated and promoted in the US online marketplace.

Lack of Widespread Adoption of Nonstigmatizing Language on Liver Transplant Center Websites

Stigmatizing language on transplant websites may deter patients with alcohol use disorder and alcohol-associated liver disease from seeking necessary medical care.

Zinc: Missing Link in HE Management?

Study reveals stark survival contrast: cirrhotic patients with normal zinc levels showed 86% survival rate versus significantly poorer outcomes in zinc-deficient patients (35.56 ± 11.65 mcg/dL, P<.0001), suggesting a potentially modifiable risk factor in hepatic encephalopathy management.